Opendata, web and dolomites

PCAGED-KI

Photocaged Kinase Inhibitors as Molecular Tools for Investigating Neurodegenerative Diseases

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 PCAGED-KI project word cloud

Explore the words cloud of the PCAGED-KI project. It provides you a very rough idea of what is the project "PCAGED-KI" about.

probe    model    responsive    unfortunately    release    time    temporal    frame    exposure    function    regulation    activation    report    quantitative    active    tyrosine    fluorescence    gt    disease    photolabile    nm    protein    lymphocyte    dynamic    employed    poorly    appropriate    valuable    cellular    aberrant    energy    group    conventional    site    spatial    320    compound    nervous    regarding    decaging    disorders    transfer    back    visualise    serving    apoptosis    reside    turn    light    proliferation    introduction    kinases    cell    inhibitors    ad    immune    enzymatic    prodrug    caging    critical    tool    onto    simultaneously    performed    kinase    form    moiety    alzheimer    manipulate    reporting    central    give    quenching    lck    activated    cns    dependent    zebrafish    effector    quencher    inhibitor    differentiation    microscopy    switching    confocal    innate    microglia    cells    play    consist    stimuli    neurodegenerative    fret    fluorescent   

Project "PCAGED-KI" data sheet

The following table provides information about the project.

Coordinator
GOETEBORGS UNIVERSITET 

Organization address
address: VASAPARKEN
city: GOETEBORG
postcode: 405 30
website: www.gu.se

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Sweden [SE]
 Project website http://grotlilab.net/research/photopharmacology/kinase-inhibitors/
 Total cost 173˙857 €
 EC max contribution 173˙857 € (100%)
 Programme 1. H2020-EU.1.3.2. (Nurturing excellence by means of cross-border and cross-sector mobility)
 Code Call H2020-MSCA-IF-2016
 Funding Scheme MSCA-IF-EF-ST
 Starting year 2017
 Duration (year-month-day) from 2017-10-01   to  2019-09-30

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    GOETEBORGS UNIVERSITET SE (GOETEBORG) coordinator 173˙857.00

Map

 Project objective

Protein kinases play a critical role in a number of cellular processes, including cell proliferation, differentiation and apoptosis. Recently, the aberrant regulation of lymphocyte-specific protein tyrosine kinases (LCK) has been associated with the over activation of microglia cells (important immune effector cells that reside in the central nervous system, CNS) and in turn, the development of Alzheimer’s disease (AD). Unfortunately, the detail of LCK's dynamic function and the importance of quantitative, spatial and time-dependent parameters regarding microglia activation is poorly understood. As such, the ability to manipulate LCK activity using light would result in temporal control of enzymatic activity, thus serving as a valuable approach to probe the function of LCK in microglia cells and in turn, further our understanding of AD and related neurodegenerative disorders. While such studies cannot be performed using conventional LCK inhibitors, this project aims to control the enzymatic activity of LCK by the development of a stimuli-responsive release-and-report system, through the introduction of a photolabile 'caging' moiety onto a fluorescent kinase inhibitor. The caging group will also consist of an appropriate ‘quencher’, quenching the innate fluorescence properties of the inhibitor through energy transfer (FRET). Exposure to light (> 320 nm) will result in decaging of the prodrug to give the active form, while simultaneously switching ‘on’ the fluorescence — reporting back to the user that the compound has been activated. To demonstrate the potential of the release-and-report kinase inhibitor as a tool to probe LCK function in microglia cells, confocal microscopy will be employed to visualise the site of microglia activation and the time frame during CNS development in zebrafish model systems.

 Publications

year authors and title journal last update
List of publications.
2019 Cassandra L. Fleming, Morten Grøtli, Joakim Andréasson
On‐Command Regulation of Kinase Activity using Photonic Stimuli
published pages: 318-326, ISSN: 2367-0932, DOI: 10.1002/cptc.201800253
ChemPhotoChem 3/6 2020-02-12
2018 Cassandra L. Fleming, Shiming Li, Morten Grøtli, Joakim Andréasson
Shining New Light on the Spiropyran Photoswitch: A Photocage Decides between cis – trans or Spiro-Merocyanine Isomerization
published pages: 14069-14072, ISSN: 0002-7863, DOI: 10.1021/jacs.8b09523
Journal of the American Chemical Society 140/43 2020-02-12
2019 Cassandra L. Fleming, Patrick A. Sandoz, Tord Inghardt, Björn Önfelt, Morten Grøtli, Joakim Andréasson
A Fluorescent Kinase Inhibitor that Exhibits Diagnostic Changes in Emission upon Binding
published pages: 15000-15004, ISSN: 1433-7851, DOI: 10.1002/anie.201909536
Angewandte Chemie International Edition 58/42 2020-02-12

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "PCAGED-KI" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "PCAGED-KI" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.1.3.2.)

Cata-rotors (2019)

Visualising age- and cataract-related changed within cell membranes of human eye lens using molecular rotors

Read More  

ParkIFNAR (2020)

Soluble IFNAR2 in Parkinson's disease and its role in the regulation of IFNβ in a neuroinflammatory context.

Read More  

GENESIS (2020)

unveilinG cEll-cell fusioN mEdiated by fuSexins In chordateS

Read More